DAVID SCHAFFER - 27 Sep 2021 Form 4 Insider Report for 4D Molecular Therapeutics Inc. (FDMT)

Role
Director
Signature
/s/ August J. Moretti, Attorney-in-Fact for David Schaffer
Issuer symbol
FDMT
Transactions as of
27 Sep 2021
Net transactions value
-$1,060,518
Form type
4
Filing time
29 Sep 2021, 16:05:11 UTC
Previous filing
19 May 2021
Next filing
01 Oct 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FDMT Common Stock Sale $426,076 -13,075 -1.3% $32.59 986,925 27 Sep 2021 Direct F1, F2, F3
transaction FDMT Common Stock Sale $206,330 -6,157 -0.62% $33.51 980,768 27 Sep 2021 Direct F1, F4
transaction FDMT Common Stock Sale $3,419 -100 -0.01% $34.19 980,668 27 Sep 2021 Direct F1
transaction FDMT Common Stock Sale $421,493 -13,812 -1.4% $30.52 966,856 28 Sep 2021 Direct F1, F5
transaction FDMT Common Stock Sale $3,200 -100 -0.01% $32.00 966,756 28 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 The transaction was executed in multiple trades in prices ranging from $32.09 to $33.09, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 Since the date of the reporting person's last ownership report, he transferred 1,000,000 shares of FDMT common stock to his ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his ex-spouse.
F4 The transaction was executed in multiple trades in prices ranging from $33.10 to $34.01, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5 The transaction was executed in multiple trades in prices ranging from $30.28 to $31.19, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.